GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Predictive Technology Group Inc (OTCPK:PRED) » Definitions » Net Income (Continuing Operations)

Predictive Technology Group (Predictive Technology Group) Net Income (Continuing Operations) : $-68.28 Mil (TTM As of Mar. 2021)


View and export this data going back to 2007. Start your Free Trial

What is Predictive Technology Group Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Predictive Technology Group's Net Income (Continuing Operations) for the three months ended in Mar. 2021 was $-7.42 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2021 was $-68.28 Mil.


Predictive Technology Group Net Income (Continuing Operations) Historical Data

The historical data trend for Predictive Technology Group's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Predictive Technology Group Net Income (Continuing Operations) Chart

Predictive Technology Group Annual Data
Trend Aug06 Aug07 Jun16 Jun17 Jun18 Jun19 Jun20
Net Income (Continuing Operations)
Get a 7-Day Free Trial -16.63 -6.21 -6.13 -15.42 -85.90

Predictive Technology Group Quarterly Data
Nov07 Feb08 May08 Jun16 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.73 -38.23 -15.49 -7.14 -7.42

Predictive Technology Group Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-68.28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Predictive Technology Group  (OTCPK:PRED) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.


Predictive Technology Group Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Predictive Technology Group's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.


Predictive Technology Group (Predictive Technology Group) Business Description

Traded in Other Exchanges
N/A
Address
2735 Parleys Way, Suite 205, Salt Lake City, UT, USA, 84109
Predictive Technology Group Inc (PRx) is a biotechnology company. It develops, commercializes, acquires and invests in technologies engaged in novel molecular diagnostic and therapeutic products in healthcare. The HCT/P segment offers minimally manipulated tissue products intended for homologous use, prepared utilizing proprietary extraction methods that reduce the loss of important scaffolding, growth factors and cytokines. The company's Diagnostics and Therapeutics segment uses data analytics for disease identification and subsequent therapeutic intervention through novel gene-based diagnostics, and companion therapeutics. It generates most of its revenues from HCT/Ps segment.

Predictive Technology Group (Predictive Technology Group) Headlines

From GuruFocus

Predictive Technology Group Provides Stock Trading Platform Update

By Marketwired Marketwired 11-11-2019

Predictive Laboratories Launches FertilityDX™

By Marketwired Marketwired 10-14-2019